| Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals HC Gerstein, JFE Mann, Q Yi, B Zinman, SF Dinneen, B Hoogwerf, ... Jama 286 (4), 421-426, 2001 | 3323 | 2001 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2276 | 2006 |
| Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial F Ismail-Beigi, T Craven, MA Banerji, J Basile, J Calles, RM Cohen, ... The Lancet 376 (9739), 419-430, 2010 | 1842 | 2010 |
| Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association JP Bantle, J Wylie-Rosett, AL Albright, CM Apovian, NG Clark, MJ Franz, ... Diabetes care 31, S61-S78, 2008 | 1642 | 2008 |
| Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications MJ Franz, JP Bantle, CA Beebe, JD Brunzell, JL Chiasson, A Garg, ... Diabetes care 25 (1), 148-198, 2002 | 1594 | 2002 |
| The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study DE Bonds, ME Miller, RM Bergenstal, JB Buse, RP Byington, JA Cutler, ... Bmj 340, 2010 | 1205 | 2010 |
| Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22 EY Chew, ML Klein, FL Ferris, NA Remaley, RP Murphy, K Chantry, ... Archives of ophthalmology 114 (9), 1079-1084, 1996 | 1112 | 1996 |
| Ramipril and the development of diabetes S Yusuf, H Gerstein, B Hoogwerf, J Pogue, J Bosch, BHR Wolffenbuttel, ... Jama 286 (15), 1882-1885, 2001 | 763 | 2001 |
| Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial R Pop-Busui, GW Evans, HC Gerstein, V Fonseca, JL Fleg, BJ Hoogwerf, ... Diabetes care 33 (7), 1578-1584, 2010 | 686 | 2010 |
| Use of twice-daily exenatide in basal insulin–treated patients with type 2 diabetes: a randomized, controlled trial JB Buse, RM Bergenstal, LC Glass, CR Heilmann, MS Lewis, AYM Kwan, ... Annals of internal medicine 154 (2), 103-112, 2011 | 670 | 2011 |
| Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study JB Buse, M Nauck, T Forst, WHH Sheu, SK Shenouda, CR Heilmann, ... The Lancet 381 (9861), 117-124, 2013 | 641 | 2013 |
| The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial B Zinman, BJ Hoogwerf, S Durán García, DR Milton, JM Giaconia, DD Kim, ... Annals of internal medicine 146 (7), 477-485, 2007 | 600 | 2007 |
| Aspirin effects on mortality and morbidity in patients with diabetes mellitus: Early Treatment Diabetic Retinopathy Study report 14 A Kassoff, SM Buzney, JW McMeel, JJ Weiter, GJ Doyle, RL Immerman, ... Jama 268 (10), 1292-1300, 1992 | 486 | 1992 |
| Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy E Lonn, S Yusuf, B Hoogwerf, J Pogue, Q Yi, B Zinman, J Bosch, ... Diabetes care 25 (11), 1919-1927, 2002 | 449 | 2002 |
| Nutrition principles for the management off diabetes and related complications MJ Franz, ES Horton, JP Bantle, CA Beebe, JD Brunzell, AM Coulston, ... Diabetes care 17 (5), 490-518, 1994 | 426 | 1994 |
| Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects JP Bantle, DC Laine, GW Castle, JW Thomas, BJ Hoogwerf, FC Goetz New England Journal of Medicine 309 (1), 7-12, 1983 | 419 | 1983 |
| Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review VR Aroda, RR Henry, J Han, W Huang, MB DeYoung, T Darsow, ... Clinical therapeutics 34 (6), 1247-1258. e22, 2012 | 351 | 2012 |
| Neuroglycopenic and other symptoms in patients with insulinomas AM Dizon, S Kowalyk, BJ Hoogwerf The American journal of medicine 106 (3), 307-310, 1999 | 340 | 1999 |
| Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass … GL Knatterud, Y Rosenberg, L Campeau, NL Geller, DB Hunninghake, ... Circulation 102 (2), 157-165, 2000 | 330 | 2000 |
| Serum uric acid is an independent predictor of all‐cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS … AG Ioachimescu, DM Brennan, BM Hoar, SL Hazen, BJ Hoogwerf Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 322 | 2008 |
